|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Clinical Nephrology |
Department of Pediatrics and Pathology, Yoshida Hospital, Niigata, Japan
Address correspondence to: Dr. Masanori Hara, Department of Pediatrics, Yoshida Hospital, Tsubame City, 959-0242 Niigata, Japan. Phone: +81-256-92-5111; Fax: +81-256-92-2610; E-mail: mhara{at}yhp-unet.ocn.ne.jp
Recent studies have revealed that podocytopenia leads to glomerular scarring and that the loss of podocytes into the urine may be a cause of podocytopenia. The purpose of this study was to examine whether serial examinations of urinary podocytes (u-podo) could be a useful predictor of disease progression in children with glomerulonephritis. Urine samples and renal biopsy specimens from 20 patients (10 males and 10 females; mean age 11.8 yr; range 4 to 24 yr) with IgA nephropathy (n = 17) and Henoch-Schönlein purpura nephritis (n = 3) were analyzed. Forty-four renal biopsies were performed on 20 patients. Proteinuria (g/d per 1.73 m2), hematuria (score), and u-podo (cells/ml) were examined twice a month in 24 intervals between two biopsies (mean 16.7 mo; range 4 to 58 mo) and average and cumulative values were determined for the intervals. Renal histologic changes were scored on the basis of acute intracapillary, acute extracapillary, acute tubulointerstitial, chronic intracapillary, chronic extracapillary, and chronic tubulointerstitial lesions, as well as glomerulosclerosis. It was found that hematuria, proteinuria, u-podo, and acute lesion scores decreased during the intervals examined, whereas chronic lesion scores increased. Changes in acute histology scores correlated well with hematuria, proteinuria, and u-podo excretion, whereas chronic histology scores and glomerulosclerosis both correlated well with cumulative u-podo excretion. Patients with severe histologic progression of disease also had persistent u-podo excretion. These findings provide additional data to support a potential causative role for prolonged urinary loss of podocytes in disease progression in children with IgA nephropathy and Henoch-Schönlein purpura nephritis.
Related Article
J. Am. Soc. Nephrol. 2007 18: 913-922.
This article has been cited by other articles:
![]() |
Y. Sato, B. L. Wharram, S. K. Lee, L. Wickman, M. Goyal, M. Venkatareddy, J. W. Chang, J. E. Wiggins, C. Lienczewski, M. Kretzler, et al. Urine Podocyte mRNAs Mark Progression of Renal Disease J. Am. Soc. Nephrol., May 1, 2009; 20(5): 1041 - 1052. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. N. Sussman, T. Sun, R. M. Krofft, and R. V. Durvasula SPARC Accelerates Disease Progression in Experimental Crescentic Glomerulonephritis Am. J. Pathol., May 1, 2009; 174(5): 1827 - 1836. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Skoberne, A. Konieczny, and M. Schiffer Glomerular epithelial cells in the urine: what has to be done to make them worthwhile? Am J Physiol Renal Physiol, February 1, 2009; 296(2): F230 - F241. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. N. Lai, J. C. K. Leung, L. Y. Y. Chan, M. A. Saleem, P. W. Mathieson, K. Y. Tam, J. Xiao, F. M. Lai, and S. C. W. Tang Podocyte injury induced by mesangial-derived cytokines in IgA nephropathy Nephrol. Dial. Transplant., January 1, 2009; 24(1): 62 - 72. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Achenbach, M. Mengel, I. Tossidou, I. Peters, J.-K. Park, M. Haubitz, J. H. Ehrich, H. Haller, and M. Schiffer Parietal epithelia cells in the urine as a marker of disease activity in glomerular diseases Nephrol. Dial. Transplant., October 1, 2008; 23(10): 3138 - 3145. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |